Embrace Scar Therapy Device for Scarring After Wound Closure

Recruiting in Palo Alto (17 mi)

Overseen byDaniel B Eisen, MD

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: University of California, Davis

Trial Summary

What is the purpose of this trial?The purpose of this study is to determine whether the use of the embrace device after repair of linear cutaneous surgery wounds improves scar cosmesis.

Eligibility Criteria

This trial is for adults over 18 who can consent, apply dressings themselves, and return for follow-ups. They're scheduled for skin surgery with a wound that's expected to close up right away and is suitable for the Embrace device. It's not for those under 18, incarcerated, allergic to adhesives, pregnant women, mentally handicapped individuals or anyone with collagen vascular disease.

Inclusion Criteria

I am scheduled for a skin surgery that can be closed up right after.

Able to give informed consent themselves

I can apply dressings by myself.

+2 more

Exclusion Criteria

Patients with known adverse reactions to adhesives

I cannot understand written or spoken English.

Patients with history of collagen vascular disease

+5 more

Participant Groups

The study tests if the Embrace Scar Therapy Device improves how scars look after surgical wounds heal compared to standard care. Participants will be assigned to use the device or receive regular treatment without it following their skin surgery.

2Treatment groups

Experimental Treatment

Placebo Group

Group I: Embrace Scar Therapy DeviceExperimental Treatment1 Intervention

16x5-cm silicone elastomeric dressing that adheres to the skin using a pressure-sensitive silicone adhesive will be applied to 1/2 of the cutaneous wound

Group II: Standard of CarePlacebo Group1 Intervention

Another 1/2 of cutaneous wound will be treated per standard of care